首页> 美国卫生研究院文献>Elsevier Sponsored Documents >Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm open-label pilot study

【2h】

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm open-label pilot study

机译：侵袭性血液系统恶性肿瘤患者的基于图像的体外药物筛选：单臂开放标签先导研究的中期结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Elsevier Sponsored Documents
作者
Berend Snijder; Gregory I Vladimer; Nikolaus Krall; Katsuhiro Miura; Ann-Sofie Schmolke; Christoph Kornauth; Oscar Lopez de la Fuente; Hye-Soo Choi; Emiel van der Kouwe; Sinan Gültekin; Lukas Kazianka; Johannes W Bigenzahn; Gregor Hoermann; Nicole Prutsch; Olaf Merkel; Anna Ringler; Monika Sabler; Georg Jeryczynski; Marius E Mayerhoefer; Ingrid Simonitsch-Klupp; Katharina Ocko; Franz Felberbauer; Leonhard Müllauer; Gerald W Prager; Belgin Korkmaz; Lukas Kenner; Wolfgang R Sperr; Robert Kralovics; Heinz Gisslinger; Peter Valent; Stefan Kubicek; Ulrich Jäger; Philipp B Staber; Giulio Superti-Furga;
展开▼
作者单位

展开▼
年(卷),期 -1(4),12
年度 -1
页码 e595–e606
总页数 25
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies [J] . Laura Beaton, Henry F J Tregidgo, Sami A Znati, JMIR Research Protocols . 2019,第10期

机译：维罗纳议定书：飞行员，开放式标签，单臂，阶段0，Vandetanib洗脱的无线电话栓塞珠粒（BTG-002814）的机会研究患者，患有可重症的肝脏恶性肿瘤患者
2. P3.01-036 A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Na?ve Patients with EGFRm+ NSCLC: An Interim Analysis [J] . Y. Wu, H. Tu, J. Feng, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P3.01-036 A IIIB阶段开放标签，EGFRM + NSCLC患者在EGFR TKI-NA'VE患者中的单臂研究：临时分析
3. Validation of the G8 screening tool in older patients with aggressive haematological malignancies [J] . VelgheA., PetrovicM., DeBuyserS., European journal of oncology nursing: the official journal of European Oncology Nursing Society . 2014,第6期

机译：G8筛查工具在侵袭性血液恶性肿瘤老年患者中的验证
4. IMANI-1 TC3WP Single Drug HAART -Proof of Concept Study Pilot Study of the Safety and Efficacy of Kaletra (LPV/r) as Single Drug HAART in HIV+ ARV- Naive Patients - Interim Analysis of Subjects Completing Final 48 Week Data [C] . J.C. Gathe Jr., M. Washington, C. Mayberry International AIDS Conference . 2004

机译：Imani-1 TC3WP单药搭载概念研究试验试验研究Kaletra（LPV / R）作为艾滋病毒+ ARV天真患者单药HAART的安全性和有效性 - 临时分析受试者完成最终的48周数据
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Efficacy and safety of buparlisib a PI3K inhibitor in patients with malignancies harboring a PI3K pathway activation: a phase 2 open-label single-arm study [O] . Sarina A. Piha-Paul, Matthew H. Taylor, Daniel Spitz, 2019

机译：PI3K抑制剂buparlisib在具有PI3K途径激活的恶性肿瘤患者中的有效性和安全性：2期开放性单臂研究
7. A Phase 1/2 Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma in the First Salvage Setting: Interim Results [O] . LaCasce Ann, Sawas Ahmed, Bociek R. Gregory, 2014

机译：1/2期单臂开放标签研究旨在评估布伦妥昔单抗Vedotin联合苯达莫司汀在首次抢救中对霍奇金淋巴瘤患者的安全性和有效性：中期结果

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm open-label pilot study

著录项

引文网络

相似文献

相关主题

期刊订阅